Gene Therapy Sponsors Risk Additional Work With Late-Stage Manufacturing Changes

 
• By Derrick Gingery
  
pharmaceutical manufacturing
An OTP official said pre-IND teleconference requests may be converted to written response only because of the agency's growing workload in the space. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies